Appropriate indications for endoscopic submucosal dissection of early gastric cancer according to tumor size and histologic type

被引:49
作者
Lee, Tae Hee [1 ]
Cho, Joo Young [1 ]
Chang, Young Woon [2 ]
Kim, Jin-Oh [1 ]
Lee, Joon Seong [1 ]
Cho, Won Young [1 ]
Kim, Hyun Gun [1 ]
Kim, Wan Jung [1 ]
Park, Youn Sun [1 ]
Jin, So Young [1 ]
机构
[1] SoonChunHyang Univ Hosp, Inst Digest Res, Ctr Digest Dis, Seoul, South Korea
[2] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
LYMPH-NODE METASTASIS; INTESTINAL-TYPE; RESECTION; CARCINOMA; DIFFUSE;
D O I
10.1016/j.gie.2009.12.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background: Endoscopic submucosal dissection (ESD) is increasingly being performed for early gastric cancers (EGCs) that are larger than 2 cm and those that are not intestinal-type (IT) cancers by Lauren's classification. The technical feasibility of ESD for these EGCs has not been fully evaluated. Objective: To identify appropriate expanded indications for ESD of EGG. Design and Setting: A retrospective analysis of prospectively collected data was performed on consecutive patients who underwent ESD at a single tertiary center. Patients and Methods: In total, 487 EGCs in 461 patients treated by ESD were classified by size and histologic type: IT EGCs 2 cm or less (257 lesions in 235 patients), IT EGCs larger than 2 cm (172 lesions in 168 patients), and non-IT EGCs (58 lesions in 58 patients). Main Outcome Measurements: Curative resections were assessed among the 3 groups, and logistic regression analysis was used to analyze factors related to curative resection. Results: The rates of curative resection significantly decreased from IT EGCs 2 cm or less (88.7%) to IT EGCs larger than 2 cm (73.3%) to non-IT EGCs (37.9%). Tumor size (>3 cm), ulceration, histologic type (non-IT), and piecemeal resection were independently unfavorable factors in curative resection. Limitations: Small sample size and short-term duration of follow-up study. Conclusions: ESD with curative intent is technically most feasible for nonulcerative and IT EGCs smaller than 3 cm. (Gastrointest Endosc 2010;71:920-6.)
引用
收藏
页码:920 / 926
页数:7
相关论文
共 23 条
[1]
PREOPERATIVE EVALUATION OF GASTRIC-CANCER BY ENDOSCOPIC ULTRASOUND [J].
AKAHOSHI, K ;
MISAWA, T ;
FUJISHIMA, H ;
CHIJIIWA, Y ;
MARUOKA, A ;
OHKUBO, A ;
NAWATA, H .
GUT, 1991, 32 (05) :479-482
[2]
[Anonymous], 2000, WHO CLASSIFICATION T
[3]
Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study [J].
Chung, Ii-Kwun ;
Lee, Jun Haeng ;
Lee, Suck-Ho ;
Kim, Sun-Joo ;
Cho, Joo Young ;
Cho, Won Young ;
Hwangbo, Young ;
Keum, Bo Ra ;
Park, Jong Jae ;
Chun, Hoon-Jai ;
Kim, Hoi Jin ;
Kim, Jae J. ;
Ji, Sam-Ryong ;
Seol, Sang Young .
GASTROINTESTINAL ENDOSCOPY, 2009, 69 (07) :1228-1235
[4]
Endoscopic resection of early gastric cancer [J].
Gotoda, Takuji .
GASTRIC CANCER, 2007, 10 (01) :1-11
[5]
Incidence of lymph node metastasis from early gastric cancer: Estimation with a large number of cases at two large centers [J].
Gotoda T. ;
Yanagisawa A. ;
Sasako M. ;
Ono H. ;
Nakanishi Y. ;
Shimoda T. ;
Kato Y. .
Gastric Cancer, 2000, 3 (4) :219-225
[6]
Preoperative staging of gastric adenocarcinoma: Comparison of helical CT and endoscopic US [J].
Habermann, CR ;
Weiss, F ;
Riecken, R ;
Honarpisheh, H ;
Bohnacker, S ;
Staedtler, C ;
Dieckmann, C ;
Schoder, V ;
Adam, G .
RADIOLOGY, 2004, 230 (02) :465-471
[7]
Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success [J].
Imagawa, A. ;
Okada, H. ;
Kawahara, Y. ;
Takenaka, R. ;
Kato, J. ;
Kawamoto, H. ;
Fujiki, S. ;
Takata, R. ;
Yoshino, T. ;
Shiratori, Y. .
ENDOSCOPY, 2006, 38 (10) :987-990
[8]
Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study [J].
Isomoto, H. ;
Shikuwa, S. ;
Yamaguchi, N. ;
Fukuda, E. ;
Ikeda, K. ;
Nishiyama, H. ;
Ohnita, K. ;
Mizuta, Y. ;
Shiozawa, J. ;
Kohno, S. .
GUT, 2009, 58 (03) :331-336
[9]
Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10
[10]
Japanese Gastric Cancer Association, 2004, GASTR CANC TREATM GU, V2nd